|
|
Volumn 13, Issue 1, 2000, Pages 1-2
|
|
Methodological challenges in the clinical development of antipsychotic drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
PLACEBO;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
EDITORIAL;
EUROPE;
HUMAN;
MEDICAL ETHICS;
MULTICENTER STUDY;
PATIENT SELECTION;
PSYCHOPHARMACOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
UNITED STATES;
|
|
EID: 0033969133
PISSN: 09517367
EISSN: None
Source Type: Journal
DOI: 10.1097/00001504-200001000-00001 Document Type: Editorial |
|
Times cited : (1)
|
|
References (11)
|
